152 related articles for article (PubMed ID: 28084712)
21. Safety of long acting muscarinic antagonists: are all these drugs always and equally safe?
Melani AS; Sestini P
Curr Med Res Opin; 2016 May; 32(5):975-7. PubMed ID: 26789695
[TBL] [Abstract][Full Text] [Related]
22. Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD.
Kardos P; Worsley S; Singh D; Román-Rodríguez M; Newby DE; Müllerová H
Int J Chron Obstruct Pulmon Dis; 2016; 11():2885-2895. PubMed ID: 27932872
[TBL] [Abstract][Full Text] [Related]
23. [Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)].
Osztovits J; Fehér J
Orv Hetil; 2010 May; 151(18):749-50. PubMed ID: 20410002
[No Abstract] [Full Text] [Related]
24. The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.
Feldman GJ; Edin A
Ther Adv Respir Dis; 2013 Dec; 7(6):311-9. PubMed ID: 24004659
[TBL] [Abstract][Full Text] [Related]
25. Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines.
Davidson JF; Donohue JF; Ohar JA
Expert Opin Drug Saf; 2015 Feb; 14(2):317-24. PubMed ID: 25598422
[TBL] [Abstract][Full Text] [Related]
26. [Are there cardiovascular adverse effects of inhaled anticholinergics?].
Nagy LB
Orv Hetil; 2015 Aug; 156(31):1246-52. PubMed ID: 26211748
[TBL] [Abstract][Full Text] [Related]
27. [After diagnosis 11 more years remain. COPD alarm in Europe!].
Wepner U
MMW Fortschr Med; 2002 Oct; 144(44):12-3. PubMed ID: 12494590
[No Abstract] [Full Text] [Related]
28. [Long-acting bronchodilator agents are the choice in COPD. Keeping the airways open continuously].
MMW Fortschr Med; 2007 Nov; 149(47):54. PubMed ID: 18064817
[No Abstract] [Full Text] [Related]
29. Dose response of umeclidinium administered once or twice daily in patients with COPD: a pooled analysis of two randomized, double-blind, placebo-controlled studies.
Donohue JF; Kalberg C; Shah P; Beerahee M; Mehta R; Gunawan R; Church A
J Clin Pharmacol; 2014 Nov; 54(11):1214-20. PubMed ID: 24895108
[TBL] [Abstract][Full Text] [Related]
30. [When beta-mimetic and anticholinergic agents fail in COPD. More air with theophylline].
MMW Fortschr Med; 2004 Apr; 146(18):57. PubMed ID: 15366477
[No Abstract] [Full Text] [Related]
31. Tiotropium in chronic obstructive pulmonary disease.
O'Connor AB
N Engl J Med; 2009 Jan; 360(2):185-6; author reply 187. PubMed ID: 19137624
[No Abstract] [Full Text] [Related]
32. Combined salmeterol and fluticasone for COPD.
Khamis RY; Rajakulasingam RK
Lancet; 2003 May; 361(9369):1652; author reply 1652-3. PubMed ID: 12747905
[No Abstract] [Full Text] [Related]
33. [Pneumology. Should we fear inhaled anticholinergic bronchodilators?].
Rochat T; Janssens JP
Rev Med Suisse; 2009 Jan; 5(186):135-7. PubMed ID: 19238933
[TBL] [Abstract][Full Text] [Related]
34. Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease.
Matera MG; Rogliani P; Rinaldi B; Cazzola M
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):35-41. PubMed ID: 25382021
[TBL] [Abstract][Full Text] [Related]
35. Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease?
Baloira A
Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):17-24. PubMed ID: 23551020
[TBL] [Abstract][Full Text] [Related]
36. Initial assessment of single and repeat doses of inhaled umeclidinium in patients with chronic obstructive pulmonary disease: two randomised studies.
Tal-Singer R; Cahn A; Mehta R; Preece A; Crater G; Kelleher D; Pouliquen IJ
Eur J Pharmacol; 2013 Feb; 701(1-3):40-8. PubMed ID: 23276660
[TBL] [Abstract][Full Text] [Related]
37. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
[TBL] [Abstract][Full Text] [Related]
38. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator].
Izquierdo Alonso JL
An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035
[TBL] [Abstract][Full Text] [Related]
39. Tiotropium: a potential replacement for ipratropium in patients with COPD.
Shukla VK
Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
[TBL] [Abstract][Full Text] [Related]
40. [Bronchodilator therapy of COPD].
Kirsten AM; Watz H; Magnussen H
Dtsch Med Wochenschr; 2014 Feb; 139(6):264-7. PubMed ID: 24473845
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
